WHO ICTRP trial
A double blind (sponsor open) placebo-controlled, stratified, parallel group…
NL-OMON46085 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON46085 |
|---|---|
| Public title | A double blind (sponsor open) placebo-controlled, stratified, parallel group study to evaluate the efficacy and safety of repeat doses of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD) (207972) |
| Scientific title | A double blind (sponsor open) placebo-controlled, stratified, parallel group study to evaluate the efficacy and safety of repeat doses of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD) (207972) - 207972 |
| Primary sponsor | GlaxoSmithKline |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | France;Netherlands;United Kingdom |
| Conditions | bronchial asthma; asthma;10006436;bronchial asthma; asthma |
| Interventions | Treatment with GSK3772847 or placebo on top of standard therapy. ;asthma;fungal allergy;GSK3772847;placebo |
| Registration date | Jul 17, 2018 |
| Target size | 4 |
| Secondary IDs | 2017-003544-20;NL65598.100.18;www.gskclinicalstudyregister.com onder studieID 207972 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: